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Executive summary
Key findings
The audit shows continuous improvement in a number of aspects 
of the quality of care for patients following heart attack. 
Immediate (primary) percutaneous coronary intervention (PCI) is 
now established as the preferred way to reopen a blocked artery 
(reperfusion) in ST-elevation myocardial infarction (STEMI). PCI 
rates increased in all nations covered in this report. Of patients 
who received reperfusion, 98% received PCI. 
The rate of primary PCI in Wales (80%) is significantly lower than in 
England (99%) or Northern Ireland (92%), but is increasing steadily 
(from 30% in 2010-11). 
Most hospitals are providing PCI to the majority of their patients 
within the recommended1 time frames of 150 minutes from call for 
help, and 120 minutes from arrival at the hospital. Overall, 77% of 
patients are treated within 150 minutes of calling for help. Four in 
every five patients with STEMI are taken by ambulance directly to 
a hospital capable of providing primary PCI. For these, half receive 
PCI within 113 minutes of calling for help. For those who undergo 
PCI having first been assessed at another (non-interventional) 
hospital, half receive PCI within 145 minutes of calling for help.
89% of patients are treated with PCI within 90 minutes of arrival 
at hospital – the equivalent figure being 52% ten years ago 
(2004-05 report). 
Patients suffering non-ST-elevation myocardial infarction 
(nSTEMI), may not require such urgent treatment but often 
have a worse long-term prognosis. This report shows year-
on-year increases in the proportion of nSTEMI patients being 
admitted to a cardiac unit, being seen by a cardiologist and being 
referred for angiography – all measures that are linked to better 
patient outcomes. 
However, despite improvements, in England, only 56.5% of nSTEMI 
patients are admitted to a cardiac unit; this is lower than in Wales 
and Northern Ireland. 
This report looks at heart attack treatment in England, 
Wales and Northern Ireland. It looks at the whole process 
from the call to the emergency services, to the prescription 
of preventive medications on discharge from hospital. It 
is based on data submitted by hospitals and emergency 
services, and is intended to cover every heart attack that 
is diagnosed. 
Importantly, of those patients admitted directly to a hospital 
that has angiography capability, only 55.8% of nSTEMI 
patients had an angiogram within the recommended 72 hours 
of admission to hospital. When patients are transferred from 
another hospital to undergo angiography this statistic is likely 
to be even worse. This aspect of heart attack management 
– the provision of timely angiography (and PCI if appropriate) 
in nSTEMI – is the most obvious example of sub-optimal 
care for patients with heart attack and provides the greatest 
opportunity to improve care for the most patients.
Of the major risk factors for a heart attack (high blood 
pressure, high cholesterol, diabetes and smoking), diabetes 
is shown in this audit to have been diagnosed in an increasing 
proportion of heart attack patients. As rates of Type 2 
diabetes continue to increase in the UK, the effect on heart 
attack rates may become even more significant.
People who smoke tobacco and suffer a heart attack are 
significantly younger than those who do not smoke. The 
average age at the time of heart attack is 57.9 years for male 
smokers compared with 68.1 years for men who have never 
smoked. The average age at the time of heart attack is 62.4 
years for female smokers compared with 76.5 years for 
women who have never smoked.
Recommendations
Policy Makers, Service Directors and 
Commissioners should:
  Work with others to increase public awareness of the 
predictors of heart attack (including cigarette smoking) 
and support initiatives to mitigate these risk factors.
  Support initiatives that raise awareness of the signs and 
symptoms of a heart attack, and the need for urgent 
medical attention, to reduce the numbers of patients 
presenting to health services long after the onset of 
symptoms. Late presentation is shown by this report to be 
the biggest single reason why no reperfusion treatment 
was given.
  Require participating hospitals and ambulance trusts 
to maintain (and improve) case ascertainment and data 
quality with respect to national clinical audits.
  Enter into dialogue with service providers to better 
understand reasons for variation in process and outcome 
measures of care.
1. NICE Quality standard QS68, Acute coronary syndromes in adults, 2014.
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Chief Executives, Medical Directors and Clinical Leads at 
provider centres should:
  Explore and understand variations in the care of both STEMI 
and nSTEMI patients in their own institution and compare 
their care to the best performance at a national level, 
considering ways to maintain and improve the quality of 
their services. 
  Ensure nSTEMI patients have access to timely angiography 
(within 72 hours of admission to hospital) where this 
is indicated. 
  Ensure there are sufficient resources allocated to clinical 
audit activity.
Clinicians and audit teams should:
  Ensure the data are accurate and reliably entered in a 
timely fashion.
  Interrogate the data on a regular basis, using the data to 
facilitate quality improvement initiatives.
  Remain committed to the collection of high quality data as 
outlined in the MINAP Minimum Data Standards.
Progress so far 
The previous report, for 2013/14, contained recommendations 
concerning improved data completeness, continued investment 
in cardiac audit, and timely angiography for nSTEMI.
Data quality remains an issue, particularly for case 
ascertainment for nSTEMI and data completeness for STEMI. 
In the previous report, completeness of data in certain ‘risk-
adjustment’ fields was judged inadequate (i.e. more than 
10% incomplete). Including participating hospitals with 
insufficient data may present potentially misleading risk-
adjusted mortality outcomes. Publication of risk-adjusted 
mortality in future versions of this report (see Introduction, part 
2.4) will require hospitals to submit more complete data on 
patient characteristics.
Early review of these fields does show improvement in data 
quality, with an extra 19 hospitals becoming eligible for 
inclusion in risk-adjustment modelling (at least 90% data 
completeness of key fields) over the past 12 months. Overall 
completeness of the three key data fields (age, blood pressure, 
and heart rate) rose from 81.1% in 2013-14 to 90.1% in 2014-15. 
NICOR continues to support data quality through provision 
of written data quality guidance, the introduction of a MINAP 
minimum data standard, data validation exercises and 
helpdesk support. 
Angiography for nSTEMI within the recommended 72 hours 
has barely improved since the last report. As indicated above, 
this remains an area for considerable improvement, with 
opportunities to provide more timely and effective treatment, 
leading to shorter lengths of stay in hospital, and better patient 
outcomes. NHS England has introduced a best practice tariff 
for angiography following admission to hospital with nSTEMI 
to support such quality improvement. MINAP data will be used 
to inform this initiative. This will encourage adherence to the 
minimum data entry standards for the audit.
For Patients and the Public
This report provides a national picture of care for heart 
attack in 2014/15 in England, Wales, and Northern Ireland. It 
contains information about your local hospital and ambulance 
services, which can be compared with other hospitals and with 
national averages.
The report shows that the most common reason why no 
treatment is given to reopen the blocked artery that caused 
a heart attack is that the patient delayed seeking medical 
help after the onset of symptoms. A heart attack can be 
life-threatening, if you think you or anyone else is having a 
heart attack, even if you’re not sure, you should phone 999 for 
an ambulance.
In the Introduction to this report we explain heart attacks and 
how they are treated. If you are interested in how heart attacks 
should be treated and why, you might want to read section 
1.3 of the Introduction (in particular Aims of Management). 
Section 1.8 lists NICE Quality Standards – these are the 
general standards of care that all patients should receive.
Your local health services should have systems for involving 
patients and the public in decision-making and strategic 
developments. Using the information in this report can provide 
information to help you start a discussion or ask questions of 
health organisations. 
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Title
An electrocardiogram test (ECG) can help to diagnose a heart 
attack. A confirmed diagnosis is made by blood testing, though 
it may take some hours before the proteins released into 
the blood stream during a heart attack start to appear. To be 
effective at limiting heart muscle damage, treatment must 
start before the results of such tests are available.
1.2 STEMI and nSTEMI
Heart attack patients may be divided into those with, and those 
without, ST segment elevation visible on the ECG. This leads to 
the final diagnosis, once the blood test confirms a heart attack 
has occurred, of ST-elevation myocardial infarction (STEMI) or 
non-ST elevation myocardial infarction (nSTEMI). 
ST-elevation usually means that a coronary artery is 
completely blocked - in most cases, this requires immediate 
treatment to re-open the artery (see Use of Primary PCI for 
STEMI). The absence of ST-elevation usually means that the 
coronary artery is only partly blocked.
Although patients with STEMI are at greater early risk, the 
medium to long-term outcome (in terms of recurrent heart 
attack or death) is in fact worse for those with nSTEMI. 
As this report shows, nSTEMI patients make up the majority 
of heart attacks. Like those with STEMI, they are likely to 
have better outcomes if they receive a prompt angiogram and 
treatment to restore blood supply to the heart.
The National Institute for Health and Care Excellence (NICE) 
has published a series of guidelines, quality standards, 
pathways of care and technology appraisals (all with 
supporting evidence) for the management of patients with 
STEMI and nSTEMI. These can be found at www.nice.org.uk.
1.3 Aims of management
The aims and methods of heart attack management are shown 
in Figure 1. Not all interventions are suitable for all patients 
(see also 1.5 No reperfusion). Clinicians use their judgement 
when deciding which treatments should be offered.
For patients with heart attack symptoms without ST-elevation 
(nSTEMI) there is a wide spectrum of risk (see 1.6 below for 
more detail). The NICE guideline supports the use of risk 
scoring in nSTEMI, and the MINAP dataset contains data fields 
to record this risk stratification. This allows those patients who 
would most benefit from a more interventional approach to 
be identified.
Figure 1. Management of heart attack:
Aims Methods
Prompt recognition 
of symptoms
  Public awareness 
  Education of professionals 
Accurate diagnosis   ECG
  Blood tests to measure cardiac 
enzymes (especially troponin)
Restore blood flow to the 
heart (reperfusion)
  Coronary angioplasty 
(also known as percutaneous 
coronary intervention 
(PCI) or stenting)
Or
  Coronary artery bypass graft 
(CABG)
Or
  Thrombolysis (also known 
as clot busting drugs  
or fibrinolysis)
  Medications, e.g. nitrates
Promote healing   ACE inhibitors
Prevent future 
heart attacks
  Long-term medications,  
e.g. statins, beta blockers,  
ACE inhibitors
  Lifestyle changes
Education and support, 
promotion of healthy 
lifestyles
  Cardiac rehabilitation
  Patient support groups
  Health promotion  
and information
Part One: Introduction
1. Background to heart attacks 
1.1 About heart attack
A heart attack occurs when the flow of blood to the heart 
is blocked, most often by a build-up of fat, cholesterol and 
other substances, which form a plaque in the arteries that 
feed the heart (coronary arteries). The interrupted blood 
flow can damage or destroy part of the heart muscle.2 This 
is known as a heart attack or myocardial infarction (MI).
Typical symptoms include chest pain or discomfort, 
sweating, breathlessness, and sudden changes in blood 
pressure, heart rate, and heart rhythm, which may lead to 
collapse or sudden death.
2. MAYO Clinic website, 2016.
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1.4 Angioplasty and interventional treatment for a 
heart attack
For patients with STEMI, re-opening of the blocked coronary 
artery must happen as quickly as possible. If patients delay 
too long in seeking help, or if medical services are slow in 
responding or in offering treatment, the treatment may be of 
no value.
Restoring blood flow can be achieved by primary PCI - an 
angioplasty and stent procedure - or with drugs designed 
to break down the blood clot (thrombolysis). While patients 
tend to wait a little longer for PCI than they would for 
thrombolysis, it is more likely to completely restore blood 
flow to the heart. Primary PCI is therefore the preferred 
treatment, with thrombolysis being reserved for cases where 
rapid access to primary PCI is impossible.
Many district general hospitals no longer routinely admit 
patients with STEMI. Patients are taken directly to a smaller 
number of specialised hospitals that provide PCI – these are 
sometimes called interventional heart attack hospitals (or 
Heart Attack Centres) – where a consultant-led service is 
available at all times. Sometimes, patients are transferred 
from the Heart Attack Centre to their local hospital following 
primary PCI, but often patients are discharged directly home 
after a stay in hospital of as short as 48 hours.
National guidance3 recommends that primary PCI should 
be performed in those who present within 12 hours of onset 
of symptoms as soon as possible – and within 120 minutes 
of when thrombolysis could have been given. Based on past 
experience of thrombolysis treatment this equates to PCI 
within 90 minutes of arrival at hospital (the door-to-balloon 
time) and within 150 minutes of a patient’s call for help 
(the call-to-balloon time). Results in MINAP are presented 
against these best practice standards, and against a more 
demanding ‘aspirational’ call-to-balloon target of 120 
minutes.
Ideally, ambulance crews make an accurate diagnosis, 
through expert assessment of the patient and interpretation 
of an ECG that they record in the community, before taking 
the patient directly to the nearest interventional hospital. 
Rapid PCI requires close collaboration between ambulance 
and various hospital teams.
Some hospitals, while not designated Heart Attack Centres, 
do have facilities to perform PCI. If a patient arrives with, or 
develops, STEMI at these hospitals while a cardiologist and 
clinical team are available, it makes sense to provide primary 
PCI on-site, if it can be performed safely and immediately. 
Patients treated at these hospitals are more likely to arrive 
under their own steam, or they may have been less easy to 
diagnose before arrival. As such, direct comparison with 
patients managed in Heart Attack Centres is potentially 
misleading.
If PCI cannot be performed at the local hospital, a 
subsequent transfer to an interventional hospital is 
associated with added delay and longer call-to-balloon 
times, compared with direct transfer from home to an 
interventional centre.
1.5 No reperfusion 
In some patients with STEMI, treatment to restore the 
blood flow to the heart is not appropriate. This may be 
because the patient’s arrival at hospital is so long after the 
symptoms started that the treatment will not give benefit, or 
the treatment is not suitable for the patient (e.g. they are at 
increased risk of bleeding), or because the angiogram shows 
that the coronary artery is not actually blocked (such as in 
Takotsubo syndrome).
1.6 nSTEMI and access to angiography
For nSTEMI patients, who are generally suffering a partial 
rather than complete blockage of a coronary artery, 
immediate treatment to restore blood flow, such as primary 
PCI, is not essential. Often the event can be managed with 
a combination of drug treatments. However, some patients 
with nSTEMI either continue to suffer pain associated with 
reduced blood supply to the heart, or initially appear to 
stabilise but later experience further problems. Patients can 
be assessed for such risks within a few hours of admission 
to hospital using a variety of validated risk scores, based on 
measures including age, blood pressure and heart rate on 
admission to hospital, and their ECG and blood tests.
NICE guidelines suggest that patients at intermediate 
risk (above 3% risk of further heart attack or death during 
the next six months), and those in whom it is possible 
to demonstrate some remaining partial blockage to the 
coronary artery after the acute event, should be advised to 
have a coronary angiogram within 96 hours of admission. 
Other international guidelines have encouraged significantly 
earlier angiography. The NICE Quality Standard4 suggests 
providing angiography (and then proceeding with PCI if 
appropriate) within 72 hours. The proportion of patients with 
a final diagnosis of nSTEMI (broadly reflecting the NICE 
classification of intermediate severity) who have angiography 
during their admission has increased from about 35% in 
2003 to about 80% in 2014/15. This reflects a significant 
change in management for nSTEMI.
3. NICE Quality standard QS167, Myocardial infarction with ST-segment elevation: acute management, 2013.
4. NICE Quality standard QS68, Acute coronary syndromes in adults, 2014. 
    7MINAP Thirteenth Public Report 2014
5. http://www.nice.org.uk/guidance/qs68/
However, angiography is not appropriate for all patients with 
nSTEMI and those at the very highest risk were not included 
in trials that demonstrated the benefit of routine angiography. 
Clinical judgement (as well as patient choice) needs to be 
exercised in such cases.
2. Measuring outcomes
2.1 Measurements in this report
This report focuses on what aspects of care are provided to 
patients – in other words, it measures processes. It shows 
what care a person might expect to receive if they have a 
heart attack. 
Good quality care can be defined through the processes 
measured here because they represent interventions that have 
been subject to rigorous assessments of effectiveness and/or 
appear in influential clinical guidelines. They are associated 
with better outcomes.
In the case of heart attack the most important and obvious 
outcome is survival (sometimes expressed as its opposite 
– case fatality or mortality rate). Yet even for this apparently 
straightforward outcome there are complexities with respect to 
reporting, for the following reasons: 
1. There is no ‘standard’ or ‘acceptable’ death rate against 
which to audit. 
2. In order to make fair comparisons between hospitals it is 
necessary to take into account (to adjust for) factors which 
influence survival, but are beyond the control of the hospital 
– such as age and other medical conditions. Choosing 
which factors to include in the mathematical adjustment, 
and how to address missing data, is a matter of judgement.
3. When the care of a patient with heart attack involves 
transfer between two hospitals, it becomes difficult to 
separate the role of each hospital in the eventual outcome. 
4. Hospitals that manage relatively few patients each year 
are likely to report large variations in death rate between 
years. Other national cardiac audits, such as those of Adult 
Cardiac Surgery and the Interventional audit, report rates 
over the previous 3 years to ‘smooth out’ such differences. 
5. It is unclear for how long survival should be monitored. 
To a patient, a five-year survival rate is probably a more 
important measure than a 30-day survival rate, but a five-
year survival rate will be affected by many factors that are 
beyond the control of the admitting hospital.
Other outcomes that matter to patients include: length of 
stay in hospital; readmission following discharge; adverse 
effects of interventions; symptoms after discharge; return to 
reasonable levels of physical activity and confidence; quality 
of life. Defining and collecting information on those outcomes 
that occur after hospital discharge is challenging and may 
require electronic data-linkage. Some can be appreciated only 
by asking patients ‘directly’ through use of Patient Reported 
Outcome Measures (PROMs).
2.2 NICE Quality Standards
NICE has published quality standards, expressed through 
six statements, for the management of patients with ACS to 
influence the commissioning and provision of high quality 
coordinated care for patients with heart attack.5
The Quality Statements were published in September 2014, 
and are shown as Figure 2.
Figure 2. NICE Quality Standard, QS68
NICE Quality Standards for acute coronary syndromes 
(including myocardial infarction)
1. Adults with a suspected acute coronary syndrome are 
assessed for acute myocardial infarction using the criteria 
in the universal definition of myocardial infarction.
2. Adults with nSTEMI or unstable angina are assessed for 
their risk of future adverse cardiovascular events using 
an established risk scoring system that predicts 6-month 
mortality to guide clinical management.
3. Adults with nSTEMI or unstable angina who have 
an intermediate or higher risk of future adverse 
cardiovascular events are offered coronary angiography 
(with follow-on PCI if appropriate) within 72 hours of first 
admission to hospital.
4. Adults with nSTEMI or unstable angina who are clinically 
unstable have coronary angiography (with follow-on PCI 
if indicated) as soon as possible, but within 24 hours of 
becoming clinically unstable.
5. Adults who are unconscious after cardiac arrest caused 
by suspected acute STEMI are not excluded from having 
coronary angiography (with follow–on primary PCI 
if indicated).
6. Adults with acute ST-segment-elevation myocardial 
infarction (STEMI) who present within 12 hours of onset 
of symptoms have primary percutaneous coronary 
intervention (PCI), as the preferred coronary reperfusion 
strategy, as soon as possible but within 120 minutes of the 
time when fibrinolysis could have been given.
The MINAP dataset is under review and the updated dataset 
will reflect revised NICE guidelines and technology appraisals.
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3. Background to MINAP
3.1 Principles
MINAP was established in 1999. It was founded on the 
following propositions:
  All patients should be included.
  Information should be collected as soon after treatment 
as possible.
  Participating hospitals should agree common definitions 
of clinically important variables and common standards of 
good quality care against which to audit their practice.
  The aspects of care being audited should have a proven link 
to better patient outcomes.
  A national aggregate figure should be produced, so a 
hospital could audit against agreed standards and compare 
against the national aggregate.
  Sufficient data should be recorded to allow for case-
mix adjustment and other techniques for investigating 
differences in outcomes between hospitals.
  The dataset should be revised regularly to account for the 
introduction of newer treatments.
  The audit should maintain its credibility and validity by being 
guided and supported by relevant professional bodies and 
patient groups, and be managed by a small project team.
  A publicly accessible report should be published annually.
3.2 Purpose of MINAP
The information we collect is used to:
  Check NHS organisations providing care are following 
national guidance, and see what improvements are 
being made.
  Identify variations in the quality of care in hospitals in 
England, Wales and Northern Ireland.
  Identify when patients do not have access to the best 
cardiac care.
  Identify good practice and share it with other 
healthcare organisations.
  Inform patients of the risks and benefits of different cardiac 
procedures to facilitate informed choices. 
  Facilitate research to identify improved treatments 
and interventions. 
  Provide commissioners and policy makers with information 
to improve the delivery of cardiac services.
  Link NICOR data with information from other data sources, 
for example NHS Digital provides NICOR with Office for 
National Statistics (ONS) mortality tracking information, 
to enable NICOR to calculate how long patients live after 
different kinds of treatment. 
The British Government has utilised data collected by MINAP 
to support investigatory reports. The Francis Inquiry, published 
in 2013, looked into the failings at the Mid Staffordshire NHS 
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Foundation Trust recommended “openness, transparency 
and candour throughout the system” and the development of 
“ever improving means of measuring and understanding the 
performance of individual professional teams, units and provider 
organisations”.6 MINAP was one of the first audits to make data 
available on the data.gov.uk website as part of the Transparency 
Agenda.7 Data from MINAP was also included by Professor Sir 
Bruce Keogh in the ‘data packs’ that informed his review of 14 
hospital Trusts with persistently high mortality rates.
Since MINAP began, its findings have been used as a basis for 
more than 70 peer-reviewed published studies, helping medical 
professionals, academics and the public understand more about 
heart attacks and how they are treated. Note, we do not pass on 
personal details to research groups.
Publications using MINAP data in 2015/16 are included in 
the appendices.
3.3 Organisation of MINAP
MINAP is one of six national cardiac clinical audits that 
are managed by the National Institute for Cardiovascular 
Outcomes Research (NICOR), which is part of the Institute for 
Cardiovascular Science at University College London (UCL). It 
aims to provide accurate data on cardiovascular outcomes for 
the public, healthcare providers and the medical profession. 
MINAP is commissioned by the Healthcare Quality Improvement 
Partnership (HQIP) as part of the National Clinical Audit and 
Patient Outcomes Programme (NCAPOP).
MINAP is overseen by a Steering Group of key stakeholders, 
including government and patient representatives – a list is 
available on the NICOR website www.ucl.ac.uk/nicor. The 
British Cardiovascular Society provides clinical direction and 
support. To encourage closer alignment of the national cardiac 
audits, Peter Ludman, the Clinical Lead for the National Audit 
of Percutaneous Intervention (NAPCI) is also a member of the 
MINAP Steering Group.
3.4 MINAP: Future plans
Mortality rates
Mortality rates are not included in this report. Previously, MINAP 
has included unadjusted mortality data, because many hospitals 
had provided inadequate data about those characteristics of 
patients that influence survival. However, this makes it difficult 
to compare hospitals or types of treatment. The majority of 
participating hospitals are now submitting data that will allow 
reliable risk-adjustment modelling, and so a comparison 
between hospitals, and identification of unexpectedly good 
or poor outcomes. It will also allow us to demonstrate more 
clearly that evidence-based care has a positive effect on patient 
outcomes. Some research studies using the MINAP dataset 
has already suggested this – one recent example is a paper 
published in the British Medical Journal (July 2016), “Geographic 
variation in the treatment of non-ST-segment myocardial 
infarction in the English National Health Service: a cohort study” 
(see Appendix 2).
Clinical Services Quality Measures 
NICOR is participating in NHS England’s development of Clinical 
Services Quality Measures (CSQMs). These are composite 
measures (based on multiple data items) designed to provide an 
at-a-glance indication of how well services are performing. 
They will allow for reliable and rapid comparisons to be easily 
made between similar services across the country (for example, 
units within hospitals); providing better information for patients, 
clinicians and the public. They will help patients to understand 
whether they received the best care and how different services 
(such as hospitals) compare, and they will help clinicians to 
understand whether their actions are helping improve outcomes 
for patients, and how their organisations compare with others.
The cardiac measures will initially focus on the treatment of 
patients with heart attacks. National clinical audits such as 
MINAP are an important source of this data. 
NICOR has held a public consultation on which measures to 
include. The measures are based on statistical principles and 
will be assured by clinical and technical experts.
Payment by results for angiography
NHS England and NHS Improvement are introducing a best 
practice tariff for non-ST segment elevation myocardial 
infarction (nSTEMI) from 2016/17. This is designed to encourage 
timely delivery (within 72 hours of admission) of coronary 
angiography for patients with nSTEMI, as recommended by the 
National Institute for Health and Care Excellence (NICE). MINAP 
data will be used to determine the delay of coronary angiography 
and used by commissioners within the Clinical Commissioning 
Groups (CCGs) to pay hospital trusts for this procedure based 
on performance.
Improved data collection on nSTEMI patients
We know that nSTEMI, which makes up the majority of heart 
attacks, are under-represented in MINAP, for reasons explained 
in the Introduction. We will work to capture a larger proportion of 
nSTEMI patients in future reports.
6. The Mid Staffordshire NHS Foundation Trust Public Inquiry 
(2013). Executive Summary. Available at https://www.gov.
uk/government/uploads/system/uploads/attachment_data/
file/279124/0947.pdf
7. http://data.gov.uk/dataset/minap-analyses-2013 
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Participating hospitals are requested to enter all patients with 
suspected heart attack. Approximately 90,000 records are 
uploaded each year.
The audit has been running continuously since 2000 and 
all hospitals in England, Wales and Northern Ireland that 
admit patients with ACS contribute data (except Scarborough 
General Hospital, which is intending to re-engage with the 
national audit in the next twelve months, having stopped 
submitting data in 2011).
1.2 Security and patient confidentiality
Strict security measures are in place to safeguard patient 
information. All data are encrypted on transmission and 
stored, encrypted, on NICOR servers. NICOR manages access 
control to the servers via user IDs and passwords. Patient-
identifiable data are kept strictly confidential and is only used 
for the purpose of linking records. 
Data held within NICOR are managed within a secure storage 
and processing environment within the UCL network and 
in accordance with the UCL information governance and 
security policy.
NICOR is licensed under the Data Protection Act by the 
Information Commissioner’s Office. Additionally, NICOR has 
support under section 251 of the National Health Service 
(NHS) Act 2006 (Ref: NIGB: ECC 1-06 (d)/2011).
NICOR staff recognise that confidentiality is an obligation and 
regularly undergo training to ensure understanding of the duty 
of confidentiality and how it relates to patient information.
Reports we publish will never identify any patient.
1.3 Data Completeness and Data Quality
MINAP records the vast majority of patients having STEMI in 
England, Wales and Northern Ireland. Evidence for this is that 
the number of STEMI patients receiving primary PCI in MINAP 
is similar to the number of primary PCI cases in the Adult 
Coronary Intervention Audit. 
However, we know that not all nSTEMI heart attacks are 
recorded, and this varies significantly between hospitals. 
Partly this reflects the greater difficulty in diagnosing nSTEMI 
(there are many non-coronary causes of elevation of the 
particular blood biomarker that characterises nSTEMI). 
However, under-reporting of nSTEMI appears to correlate with 
resources allocated to data collection. Non-STEMI is therefore 
under-represented in MINAP. The true number is difficult 
to establish, as it is not possible to reliably compare MINAP 
data with Hospital Episode Statistics (HES) in England or the 
Patient Episode Database for Wales (PEDW).
The completeness of the data collected by hospitals is based 
on patients recorded with nSTEMI. The completeness of a 
number of key fields is continually monitored and is available 
to hospitals in an online view that is refreshed daily. Currently 
these fields continue to be 99% complete.
MINAP has a number of approaches to support improvements 
in data quality. MINAP provides detailed data quality guidance 
and a variety of clinical scenarios to aid data entry. A dedicated 
helpdesk advises colleagues who experience problems. The 
MINAP data application contains error-checking routines, 
including range and consistency checks, designed to minimise 
common errors. In December 2014, MINAP introduced a 
minimum data standard for STEMI and nSTEMI patients and 
data quality has improved over the last 18 months. MINAP 
also carries out rigorous checks to ensure quality of data. For 
example, there is an annual data validation study to check data 
held on the NICOR servers.
Part Two: Methodology
1.1 How the information is collected
The current dataset, version 10.3.2, contains 130 fields. 
It is revised every two years to allow both continuing 
monitoring of established practices and information 
about new treatments. It is designed to capture the entire 
‘patient pathway’ – from the time the patient calls for 
professional help to the point of discharge. This includes 
patient demographics, medical history and clinical 
assessment, investigations, interventions, and treatment 
with medications before, during and after the hospital 
stay. The most recent versions of the MINAP dataset are 
available on the MINAP web pages at 
www.ucl.ac.uk/nicor/audits/minap/datasets. 
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1.4 Reporting process measures
In reporting the process measures, we include:
  All patients with a discharge diagnosis of STEMI in call-
to-balloon and door-to-balloon times. We include all 
patients that had ST segment elevation detected by ECG 
during hospitalization as well as at the time of admission 
to hospital.
  All patients with a discharge diagnosis of nSTEMI when 
reporting admissions to a cardiac ward, care under a 
specialist, and (for those admitted directly to a hospital 
with facilities to perform angiography) in reporting delay 
to angiography.
  All patients with acute coronary syndromes (both STEMI 
and nSTEMI) in reporting use of secondary prevention 
therapy and length of stay in hospital.
In addition we remove malformed entries, such as duplicates, 
and records with invalid dates. We further exclude patients 
younger than 20 years of age.
1.5 Improving analysis
NICOR’s Analysis Team uses the R statistical programming 
language to help standardise processing of data across the 
HQIP audits.
Modules for the removal of duplicate entries and the cleaning 
of date, numeric, and categorical variables have been 
developed. The cleaning rules and algorithms are regularly 
curated by the team and reviewed by the audit leads to 
ensure that the analyses are properly specified, transparent, 
and reproducible.
In advance of publication of the annual report, hospitals and 
ambulance services receive and review draft unit-specific 
process measure reports that are generated using the same 
template of calculations that are later used to compute annual 
MINAP statistics. By leveraging the group review process 
in this way, NICOR seeks to guarantee that all published 
statistics have been ‘vetted’ and are reliable.
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Heart attack was more common in men – a ratio of two men 
for every woman. This ratio has not changed significantly over 
the past five years. Male predominance was more marked 
in STEMI (71.2% male) than in nSTEMI (64.7% male). Of all 
men suffering heart attack, 42.7% experienced STEMI and 
57.3% nSTEMI. Of all women suffering heart attack, 35.5% 
experienced STEMI and 64.5% nSTEMI. 
For both STEMI and nSTEMI, women tended to be older than 
men. The average age of male STEMI patients was 63.1 years 
compared with 71.4 years for females; the average age for 
male nSTEMI patients was 68.9 years compared with 74.7 
years for females. Overall almost half of all heart attacks 
recorded in MINAP were in people over 70 years of age. Those 
with STEMI tended to be younger (average age 65.4 years) than 
those with nSTEMI (average age 71.0 years). Half of STEMI 
patients were 65 years or younger; half of nSTEMI patients 
were 72 years or older (Figure 3).
Figure 3. nSTEMI and STEMI, by age 
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Figure 4. STEMI and nSTEMI patients by age and gender
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Among those admitted with a first heart attack, and who 
had not previously undergone cardiac surgery or PCI, the 
prevalence of previously diagnosed high blood pressure 
(hypertension) for both men (43.2%) and women (54.1%) is 
similar to that reported over the past two years. Similarly, 
the prevalence of recognized and treated hyperlipidaemia (in 
most cases, high cholesterol levels managed by statins) has 
remained stable (29.9% in men and 28.8% in women).
While the prevalence of two of the major ‘modifiable’ 
risk factors for coronary disease – hypertension and 
hyperlipidaemia – has remained stable, there continues to be a 
yearly increase in the frequency of a prior diagnosis of diabetes 
(mainly Type 2 diabetes mellitus) in those experiencing a first 
heart attack; Approximately one in every five patients with 
heart attack has been diagnosed with diabetes (18.3% of male 
patients and 20.5% of female patients). This is much higher 
than the prevalence of diabetes in the general population 
(Figure 5). 
Figure 5. Proportion of heart attack patients previously 
diagnosed with diabetes
Part Three: Results and analyses
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1. Characteristics of patients with heart attack 
in 2014/15
In 2014/15, 92,258 records were submitted to the MINAP 
database from hospitals in England, Wales, Northern 
Ireland and Isle of Man. Of these, 83,842 (91%) related 
to patients with a final diagnosis of myocardial infarction 
(40.5% STEMI; 59.5% nSTEMI). Two thirds of heart attacks 
occurred in patients who had not experienced previous 
attacks, while in the remainder there was a history of 
previous episodes. 
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Figure 6. Risk factors for heart attack
Smoking is another recognised risk factor for the development 
of coronary artery disease and for heart attack. Most younger 
people suffering heart attack in MINAP are cigarette smokers. 
The average age at the time of heart attack is 57.9 years for 
male smokers compared with 68.1 years for men who have 
never smoked. The average age at the time of heart attack is 
62.4 years for female smokers compared with 76.5 years for 
women who have never smoked.
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The use of primary PCI in cases of STEMI appears to have 
reached a plateau. In 2014/15 it was provided to 98% of those 
who received any reperfusion treatment (i.e. either primary PCI 
or thrombolysis). This year in England 99% of patients were 
treated with PCI compared to 98.5% in 2013/14. In Wales 80% 
patients had primary PCI compared to 79.5% in 2013/14. This 
figure is unlikely to change substantially until the primary PCI 
service for North Wales, a predominantly rural area, becomes 
operational during 2016. In Northern Ireland 92.0% all patients 
recorded in MINAP received primary PCI in 2014/15. 
All service providers (ambulance and hospital services) are 
audited against best practice standards for providing primary 
PCI for STEMI. These standards are described in national and 
international guidance for the management of STEMI. They 
include the provision of primary PCI within 90 minutes of 
arrival at the primary PCI centre (the door-to-balloon (DTB) 
time) and within 150 minutes of a patient’s call for help (the 
call-to-balloon (CTB) time). Almost all hospitals are now 
treating the majority of their patients within a CTB time of 150 
minutes and some within a CTB of 120 minutes.
The median DTB and CTB is the delay, from arrival at hospital 
and from call for help respectively, experienced by 50% of 
patients admitted to each hospital. 
Usually, patients with a diagnosis of STEMI confirmed by a 
paramedic crew are taken directly to an interventional hospital 
(Heart Attack Centre). This is not always possible, particularly 
where the diagnosis cannot be confirmed by ambulance crews, 
or in more remote parts of the country. This leads to the need 
for transfer between hospitals, from one that cannot provide 
immediate primary PCI to one that can – as occurred in 19% of 
STEMI cases in 2014/15 – or for the use of thrombolysis (clot-
busting drugs) to restore blood flow.
2.1. Door-to-balloon time
The door-to-balloon (DTB) time is the time between the 
patient arriving at the hospital and the start of the angioplasty 
procedure. Overall, the median DTB was, as in the previous 
year, 41 minutes, with 25% treated within 29 minutes and 75% 
within 59 minutes of arrival. This measure of in-hospital delay 
to treatment was, as last year, slightly shorter (median DTB 
38 minutes) for those patients transferred to a PCI-capable 
hospital (Heart Attack Centre) following assessment at a 
non-interventional hospital than for those brought directly 
to the Heart Attack Centre (median DTB 41 minutes). This 
suggests that the staff at the Heart Attack Centre have more 
time to prepare for the arrival of those patients that have been 
assessed in another hospital. However, the more clinically 
significant call to-balloon time is longer for this group of 
patients, as section 2.2 will explain.
The percentage of patients with an admission diagnosis of 
STEMI who receive primary PCI within 90 minutes of arrival 
at a Heart Attack Centre was 52% in 2004/5, and had risen to 
92% in 2013/14. This year (2014/15) the proportion was 88.6%. 
(Figure 7). This slight fall may represent simple year-on-year 
variability, rather than any systematic reduction in quality of 
care. It still reflects a close collaboration between ambulance 
services, emergency departments and admitting hospitals. In 
particular, direct transfer of the patient by ambulance from 
the community to the catheter lab without involvement of other 
departments or wards has reduced delays. 
Figure 7. Door to balloon times for STEMI patients 
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In England this year, 88.9% of 18,986 eligible patients were 
treated with primary PCI within 90 minutes of arrival at the 
heart attack centre: compared with 92% of 17,996 in 2013/14. 
In Wales, 79% of 835 eligible patients were treated within 
90 minutes compared to 87% of 491 in 2013/14. In Northern 
Ireland, 92% of 663 eligible patients were treated within 90 
minutes. Last year, only Belfast hospitals were included in 
MINAP, and 95% of 358 eligible patients then were treated 
within 90 minutes of arrival.
STEMI Cases
2. Primary PCI for STEMI 
(see Appendix 3, Table 1)
NICE Quality Statement 6: Primary PCI for acute STEMI.
Adults with acute ST-segment-elevation myocardial 
infarction (STEMI) who present within 12 hours of onset 
of symptoms have primary percutaneous coronary 
intervention (PCI), as the preferred coronary reperfusion 
strategy, as soon as possible but within 120 minutes of the 
time when fibrinolysis could have been given.
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2.2. Call-to-balloon time
The call-to-balloon (CTB) time is the interval between a call for 
professional help and the angioplasty procedure. It depends 
on both the relevant ambulance service and the admitting 
hospital – although some patients present themselves at 
hospital with symptoms of heart attack without alerting the 
emergency services. In 2014/15 14% of all heart attacks 
recorded in MINAP were ‘self-presenters’; 5% of those whose 
diagnosis at the time of admission was ‘Definite myocardial 
infarction’ (in nearly all cases, STEMI) self-presented. 
Overall, 77% of 19,044 eligible patients were treated within 
150 minutes (and 53.6% within 120 minutes) of calling for 
professional help in 2014/15. Individual hospital performance 
with respect to this standard is presented in Table 1 
(Appendix 3). 
In England, 77% of 17,733 eligible patients were treated within 
150 minutes of calling for help (and 54% within 120 minutes). 
This is a slight drop in performance from 2013/14, when 82% 
out of 16,930 eligible patients were treated within 150 minutes, 
and 59% within 120 minutes. The median call-to-balloon time 
was 115 minutes. 
In Wales, 67% of 697 patients were treated within 150 minutes 
of calling for help (and 41% within 120 minutes), compared 
with 75% of 424 patients within 150 minutes, and 52% 
within 120 minutes in 2013/14. This apparent worsening of 
performance probably reflects a ‘roll-out’ of the more effective 
primary PCI treatment (rather than thrombolysis) to a larger 
geographical area. The median call-to-balloon time was 
126 minutes. 
In Northern Ireland, 80.8% of 614 patients were treated 
within 150 minutes of calling for help (and 60% within 120 
minutes). The comparator from 2013/14 is hospitals in 
Belfast, where 89% of 313 eligible patients were treated 
within 150 minutes, and 80% within 120 minutes. Once again, 
the apparent worsening of performance probably reflects a 
‘roll-out’ of primary PCI to a population that includes those in 
rural or remote areas. The median call-to-balloon time was 
106 minutes. 
Overall, 80% patients receiving primary PCI were admitted 
directly to interventional PCI-capable hospitals, either by 
ambulance or arriving under their own steam. Of these, 82.4% 
had a CTB within 150 minutes and 58% within 120 minutes. 
This compares with 50.7% within 150 minutes and 33.7% 
within 120 minutes for those who were transferred to the 
interventional hospital following initial assessment at another 
hospital. The median call-to-balloon time for those directly 
admitted was 113 minutes, compared with 145 minutes for 
those who were transferred between hospitals. Figure 8 shows 
the difference in CTB times between those directly admitted to 
an interventional hospital and those needing to be transferred 
between hospitals.
Figure 8. Call-to-balloon times: differences between patients 
transferred between hospitals and those who arrived directly
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In England, 80.5% patients receiving primary PCI were 
admitted directly to interventional hospitals. Of these, 82.7% 
had a CTB within 150 minutes and 58.4% within 120 minutes. 
This compares with 50.5% within 150 minutes and 32.3% 
within 120 minutes for those who had required inter-hospital 
transfer. Overall 54% of patients received primary PCI within 
120 minutes of calling for help in England. 
In Wales, 79.7% patients receiving primary PCI were admitted 
directly to interventional hospitals. Of these, 72.4% had a 
CTB within 150 minutes and 44.5% within 120 minutes. This 
compares with 26.7% within 150 minutes and 17.8% within 120 
minutes for those transferred between hospitals. Overall 41% 
of patients received primary PCI within 120 minutes of calling 
for help in Wales. 
In Northern Ireland, 71% patients receiving primary PCI were 
admitted directly to interventional hospitals. Of these, 85.5% 
had a CTB within 150 minutes and 59.6% within 120 minutes. 
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This compares with 68.1% within 150 minutes and 59.6% 
within 120 minutes for ‘inter-hospital transfers’. Overall 59.6% 
of patients received primary PCI within 120 minutes of calling 
for help in Northern Ireland.
Figure 9 shows, for those admitted directly to an interventional 
centre, the distribution of call-to-balloon times from 2010-
11 to 2014-15 and Figure 10 shows the median time from 
calling for help to arriving at the hospital (call to door). The 
time interval from call-to-door has increased – presumably 
related to a roll-out of the primary PCI service to more remote 
areas – but this has had only a limited effect on overall 
call-to-balloon delay. 
Figure 9. Distribution of call-to-balloon times over the past 
five years
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Figure 10. Distribution of call-to-door times over the past 
five years
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3. Thrombolytic treatment for STEMI 
Intravenous thrombolytic treatment (with clot-busting drugs), 
once the preferred option in the early treatment of STEMI, 
is now seldom used, except in those few areas where rapid 
access to primary PCI is not available. Its use has been 
declining over a number of years, and continued to do so in 
2014/15, falling to 462 from 601 patients in 2013/14.
When it was the standard treatment, the aim was to give 
thrombolysis within 60 minutes of a call for professional help 
– the call-to-needle time. It is questionable whether such a 
target is realistic considering the small numbers and often 
remote locations of patients who now receive thrombolysis. 
Figure 11 shows the median call-to-needle times for the 
five hospitals that have each recorded 20 or more cases of 
thrombolytic treatment for STEMI during 2014-2015. Among 
these the majority of patients were in North Wales, where a 
little under a half achieve the 60 minute call-to-needle time.
Figure 11. Call-to-Needle (CTN)
Call-to-Needle (CTN) times for those hospitals providing 
thrombolytic treatment rather than primary PCI for STEMI. 
Some of these patients may have received thrombolysis from 
ambulance paramedics before arrival at hospital
2014 - 2015
Hospital Median of 
CTN (min)
Thrombolysis 
within 60 
mins (%)
Eligible 
patients for 
CTN60 (N)
Altnagelvin 
Area Hospital, 
Northern 
Ireland
64.5 44.4 18
Glan Clwyd, 
Wales
64 46.3 41
Noble's 
Hospital, 
Isle of Man
73 88.9 9
Wrexham 
Maelor 
Hospital, 
Wales
44 48.9 47
Ysbyty 
Gwynedd, 
Wales
61 43.4 53
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4. Patients that receive no reperfusion
There remains a substantial proportion of patients with a final 
diagnosis of STEMI who do not receive treatment to restore 
blood flow through the blocked coronary artery; in 2014/15, 
26.6% - similar to the previous year. 
The most common reason offered as to why no reperfusion 
treatment was given was that it was not applicable (of no 
benefit) to patients who presented late (typically more than 12 
hours) after the onset of symptoms. This shows the importance 
of raising awareness among the public to increase recognition 
of symptoms and of the need to seek urgent medical attention. 
In a few cases, other serious illnesses such as advanced cancer, 
made reperfusion treatment inappropriate. In some cases the 
perceived risk of bleeding during or soon after reperfusion 
therapy was judged too high to allow such treatment (Figure 
12). Largely these are matters for the judgment of individual 
clinicians when the patient is first assessed.
However, in some cases when an emergency angiography has 
been performed with the intention directly to proceed with 
primary PCI, a decision may be made that PCI is not required, 
is not feasible, or should be aborted in favour of bypass surgery 
(CABG). This is one of the benefits of angiography in the early 
management of STEMI. Importantly, in MINAP those patients 
who undergo timely emergency angiography in readiness for 
primary PCI, yet who do not proceed to PCI, are coded as having 
had ‘no reperfusion’ – even if they proceed to emergency CABG. 
As such, some patients do not undergo angiography at all (see 
Figure 12), and other patients do not proceed to PCI following 
angiography (see Figure 13).
Figure 12. No angiogram or reperfusion, STEMI patients in 
England, Wales and Northern Ireland
Reason why no reperfusion 
was attempted (patients 
where no angiogram 
was performed)
Number Percentage
Administrative failure 49 0.54%
Elective decision 1368 15.12%
Ineligible ECG 2198 24.29%
Patient refused treatment 68 0.75%
Risk of haemorrhage 85 0.94%
Too late 1768 19.54%
Uncontrolled hypertension 3 0.03%
Other 1397 15.44%
None 1137 12.56%
Unknown 54 0.60%
Missing 922 10.19%
Total 9049 100%
Figure 13. Angiogram but no reperfusion, STEMI patients in 
England, Wales and Northern Ireland
Reason for no reperfusion following 
initial emergency angiogram
Total Percentage
Angiographically normal coronaries 
/ mild disease / Infarct Related 
Vessel unclear
607 12.8%
Coded not applicable 1185 24.9%
Complication before PCI could 
be performed
35 0.7%
Other 205 4.3%
Patient died 86 1.8%
Patient refused 27 0.6%
PCI felt to be inappropriate 359 7.6%
Surgical disease (i.e. patient 
proceeded to CABG)
287 6.0%
Technical failure 38 0.8%
No specific reason offered 1922 40.5%
Total 4751 100%
5. Ambulance service performance 
(see Appendix 3, Table 2)
Ambulance personnel continue to provide the earliest care 
for patients with heart attack. This includes: resuscitation 
from sudden cardiac arrest; pain relief; performing of ECG 
and continuing cardiac monitoring; (when appropriate) oxygen 
therapy; provision drugs such as aspirin, as well as professional 
reassurance to patients and their relatives.
Ambulance services are responsible for the early recognition 
of heart attack symptoms, by collaborating closely receiving 
hospitals they can promptly send an alert to the relevant 
hospital. Over recent years, their focus has shifted from 
the provision of pre-hospital thrombolytic treatment to the 
identification of those patients with STEMI who might benefit 
from primary PCI – transferring these patients rapidly to an 
interventional hospital. As previously shown for thrombolytic 
therapy, time to treatment also plays a key role in survival 
with primary PCI. For this reason, one measure of ambulance 
service performance is the overall call-to-balloon time for 
their patients receiving primary PCI, even though the PCI is 
performed within the hospital.
Table 2 (Appendix 3) shows ambulance service performance in 
England and Wales expressed as the median call-to-balloon 
time for patients who received care from ambulance personnel. 
Across the country, the average time for patients to receive 
primary PCI was 112 minutes, with individual services ranging 
from 90 to 125 minutes. Overall, 83% of patients had a CTB 
within 150 minutes and 60% within 120 minutes, although these 
figures varied between ambulance trusts. For patients treated 
within 120 minutes, the CTB times ranged from 45.8% to 81.4%.
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nSTEMI cases
As explained in Part Two, Methodology (section 1.3), the 
numbers of nSTEMI reported in MINAP are incomplete, and 
in particular it is likely that patients who are not admitted to 
a cardiac care unit are, in many cases, omitted. The quality of 
care for patients not entered into MINAP remains unknown. 
The variable nature of recording nSTEMI between hospitals 
may also distort some analyses.
Figure 14 shows how three different aspects of care for 
nSTEMI have changed over time
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6.1. Admission to cardiac unit/ward
Table 3 (in the appendices) shows the percentage of nSTEMI 
patients that were admitted to a cardiac unit or ward and 
the percentage of nSTEMI patients seen by a cardiologist or 
member of their team, by hospital, in 2013/14 and 2014/15. 
Overall, 56.9% of patients with nSTEMI were admitted to a 
cardiac unit or ward in 2014/15. In England in 2014/15, 55% 
of 45,500 nSTEMI patients were admitted to a cardiac care 
6. Care for patients with nSTEMI 
(see Appendix 3, Table 3)
Compared with STEMI, patients with nSTEMI have a lower 
early risk of death, usually do not require immediate 
reperfusion treatment, yet often present more diagnostic 
difficulties. For these reasons they are not always admitted 
to cardiac care units, nor always cared for by cardiologists. 
But the long-term outlook, in terms of risk of a second 
heart attack or death, is actually worse for nSTEMI patients. 
Specialist involvement is important, as it increases the 
likelihood of them receiving ‘evidence-based’ treatments. 
Performance of angiography and coronary intervention is 
an important aspect of treatment for most patients (see 
section 7.3 Angiography in nSTEMI). Ideally, admission 
should be to a cardiology ward or other specialist facility, 
where nursing staff have expertise in cardiac nursing and 
there is easy access to specialist advice.
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unit or ward compared with 55% in 2013/14. In Wales, 71% 
of 2,726 nSTEMI patients were admitted to a cardiac unit or 
ward compared to 65% in 2013/14. In the Northern Ireland, 88 
% of 1563 patients were admitted to a cardiac unit or ward in 
2014/15.
6.2. Specialist care during admission
Overall, cardiologists saw 94.8% of patients with nSTEMI. In 
England in 2014/15 95% of 45,500 nSTEMI patients were seen 
by a cardiologist, or member of the cardiologist’s team, during 
admission (but not necessarily admitted directly under the 
care of a cardiologist), compared with 94% in the previous two 
annual audits. In Wales, 87.6% of 2,726 nSTEMI patients were 
seen by a cardiologist or member of their team compared to 
85% in 2013/14. In Northern Ireland, cardiologists saw 99.4% 
of 1563 nSTEMI patients in 2014/15.
6.3. Angiography in nSTEMI
MINAP reports the proportion of those patients with a final 
diagnosis of nSTEMI who are eligible for and who undergo a 
diagnostic coronary angiography. The frequency with which 
patients with nSTEMI are referred for angiography has 
increased significantly over the past decade – from about a 
quarter (27%) in 2004/5 to 81.6% in 2014/15 (Figure 15 above). 
Table 3 shows the percentage of nSTEMI that were referred for 
angiography by hospital in 2013/14 and 2014/15. In 2014/15, 
79.4% of nSTEMI patients in England were referred for pre-
discharge angiography after nSTEMI compared to 78% in 
2013/14. In Wales the figure was 76.9% in 2014/15, compared 
with 80% 2013/14. In Northern Ireland 94.3% underwent 
angiography in 2014/15.
In a small number of cases, patients are discharged with 
arrangements to return for angiography later. When these are 
included, the overall rate of angiography in eligible patients 
reaches 81.6%.
6.4. Delay to angiography in nSTEMI 
While immediate angiography is not warranted in the vast 
majority of patients with nSTEMI, early angiography is 
recommended for those at moderate to high risk – defined as 
those patients with an estimated probability of death within 
the following 6 months of more than 3%. The maximum 
acceptable delay from admission to angiogram has been 
variously defined. The NICE Quality Standard document for 
ACS has suggested that high quality care is characterised by 
angiography within 72 hours of being admitted to a hospital. 
The analyses presented here have been restricted to those 
patients who were directly admitted to the hospital where 
angiography was performed. For those with reliable timings 
recorded, 17.1% had received an angiogram within the first 24 
hours after admission; 37.8% within 48 hours and 55.6% within 
72 hours. 30.4% undergo angiography more than 96 hours 
after admission. Changes to angiogram waiting times between 
2010/11 and 2014/15 are shown in Figure 15. 
Figure 15. Delay from admission to angiogram for nSTEMI 
patients (‘Direct admissions’ only)
0
2
4
6
8
10
12
14
16
2010 − 11 2011 − 12 2012 − 13 2013 − 14 2014 − 15
D
ay
s
Years
At present we cannot reliably capture the entire care pathway 
of those patients who are transferred from non-angiography-
capable hospitals to have angiography at a second hospital. It 
is likely that the overall interval from admission to angiography 
for patients transferred between hospitals is longer than for 
those admitted directly. (This has been demonstrated in the 
National Audit of PCI for those patients who go on to undergo 
PCI after angiography). The MINAP dataset now contains data 
fields that will allow the collection of reliable information 
about such patients.
Title
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Historically, MINAP has reported on the rates of prescription 
of individual secondary prevention medication at the time of 
discharge from hospital. 
Overall, the rate of use of these drugs is high (in cases where 
their usage is appropriate) – aspirin 98.3%; beta-blocker 
96.6%; either ACE inhibitor or angiotensin receptor blocker 
94.6%; statins 97.4%; either clopidogrel or prasugrel or 
ticagrelor 97.5%. 
Over the last two years a more stringent measure of hospital 
performance has been reported, by measuring the use of 
a combination of these drugs. This performance measure 
includes data for all patients with ACS, both STEMI and 
nSTEMI – regardless of what their initial hospital treatment 
was. The particular drugs, or classes of drugs, included in the 
composite indicator are aspirin; a second antiplatelet agent 
(clopidogrel or prasugrel or ticagrelor); beta-blockers; ACE 
inhibitors or angiotensin receptor blockers; and statins. The 
reported percentage represents the proportion of patients 
discharged from medical care following heart attack that 
receive all the medicines for which they are eligible. [While 
71% of patients are reported to be eligible to receive all five 
drug classes, there may be good reasons why a particular 
patient cannot be given one or more of the secondary 
prevention drugs – so using this performance measure, a 
hospital will have treated two patients equally well if one 
patient is discharged taking all five drug classes and the other 
is discharged taking three of the drug classes, having been 
identified as being ineligible to receive the other two.] Overall, 
in 2014/15, 90.5% of patients were discharged taking all the 
secondary prevention drugs for which they were eligible. The 
performance of individual hospitals is shown in Table 4 
(in the appendices).
Patients are not included in the composite score for a hospital 
if they are transferred to another hospital, or if they died 
in hospital. Due to the method of reporting, the initiation 
of secondary prevention medication prior to inter-hospital 
transfer will not be attributed in the report. As a result, the 
figures we report for non-interventional hospitals that work 
closely with interventional centres may not fully reflect the 
volume of cases initiated. 
STEMI & nSTEMI at discharge
7. Use of secondary prevention medication 
(see Appendix 3, Table 4)
NICE guidance and technology appraisals support the use of 
combinations of the following drugs in all eligible patients 
who have had an acute heart attack, in order to reduce the 
likelihood of a further heart event:
  Angiotensin converting enzyme (ACE) inhibitors
  Aldosterone antagonists (in those with evidence of 
systolic heart failure)
  Angiotensin receptor blockers (not normally in 
combination with ACE inhibitors)
  Aspirin
  Beta-blockers
  Thienopyridine inhibitors (clopidogrel or prasugrel)
  Ticagrelor
  Statins
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Figure 16. Proportion of heart attack patients receiving all 
appropriate secondary prevention medications
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8. Length of stay (see Appendix 3, Table 5)
The length of time that a patient stays in hospital following 
a heart attack is influenced by many factors. Generally, 
patients with nSTEMI spend significantly longer in hospital 
than those with STEMI. This may partly reflect the urgency 
with which primary PCI is provided in STEMI, compared with 
the less urgent provision of angiography in nSTEMI, but also 
reflects the characteristic of the patients. As reported above, 
individuals experiencing nSTEMI tend to be older and are 
therefore more likely to have associated health and social 
issues that delay their discharge home.
The analysis of length of stay reported here is only for patients 
who were managed without transfer between hospitals, 
because MINAP cannot reliably link the date of admission 
of a patient to one hospital with the date of their discharge 
from another hospital. It is likely that those transferred 
between hospitals have a longer length of stay than those 
managed in one place. Also, patients with STEMI admitted 
to and “retained” in non-interventional hospitals often have 
non-cardiac health issues that had made transfer to an 
interventional centre inadvisable. The length of stay of such 
patients is likely to be substantial longer than others.
Excluding inter-hospital transfers, in 2014/15 the median 
length of stay for patients with STEMI was 3 days (Inter 
Quartile Range (IQR) 2-5 days). In other words, a quarter of 
those admitted with STEMI had been discharged within 48 
hours of admission, half within 72 hours and three quarters 
within 120 hours. For nSTEMI the median length of stay was 
5 days (Inter Quartile Range (IQR) 3-9 days). 5% patients 
with STEMI remained in hospital more than 17 days after 
admission. 5% patients with nSTEMI remained in hospital 
more than 25 days after admission. 
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Appendix 1: Glossary
ACE inhibitors - A class of drug used after a heart attack to treat 
and prevent of heart failure. They are also used to treat high blood 
pressure. They work by making your blood vessels relax or dilate. 
Angiotensin receptor blockers (ARBs) have broadly similar effects.
Acute coronary syndrome (ACS) - This term covers all episodes that 
result from sudden and spontaneous blockage or near blockage of a 
coronary artery, including heart attack and unstable angina.
Angina - Symptoms of chest pain that occur when narrowing of the 
coronary arteries prevent enough oxygen containing blood reaching 
the heart muscle when its demands are high, such as during 
exercise. See also ‘Unstable angina’.
Angiogram - An X-ray investigation performed under a local 
anaesthetic that produces images of the flow of blood within an 
artery (in this case the coronary artery). Narrowing and complete 
blockages within the arteries can be identified and this allows 
decisions to be made regarding treatment, such as primary 
percutaneous intervention or coronary artery bypass grafting. The 
technique of producing angiograms is called angiography.
Beta blockers - Drugs used to help prevent attacks of angina, to 
lower blood pressure, to help control abnormal heart rhythms 
and to reduce the risk of further heart attack in people who have 
already had one. They work by blocking the actions of the hormone 
adrenaline, which makes the heart beat faster and more vigorously. 
They may also be used in heart failure.
Call-to-balloon time (CTB) - In heart attack treatment, the interval 
between the call for professional help and the start of primary PCI.
Cardiac rehabilitation - a programme of exercise and information 
sessions designed to help patients who have had a heart attack and 
reduce their risk of a further heart event.
Case mix - Different types of patients treated by a hospital or 
an operator
Coronary heart disease (CHD) - A group of diseases that 
includes stable and unstable angina, heart attack, and sudden 
coronary death. It is a result of the narrowing or blockage of the 
coronary arteries.
Door-to-balloon time (DTB) - In heart attack treatment, the time 
between the ambulance arriving at a PCI hospital and the start of 
primary PCI.
Elective - A procedure that is scheduled in advance because it does 
not involve a medical emergency.
Electrocardiogram (ECG) - A test to record the rhythm and electrical 
activity of the heart. The ECG can often show whether a person has 
had a heart attack, either recently or some time ago. It can also tell 
if reperfusion therapy is appropriate and if it has been effective.
Heart attack - The term applied to the symptoms, usually but not 
always involving chest pain, which develop when a clot (thrombus) 
develops within a heart artery. Usually this follows on from a gradual 
build-up of fatty material (atheroma) inside the artery (a process 
called atherosclerosis). The heart muscle supplied by the blocked 
artery suffers permanent damage if the blood supply is not restored 
quickly. The damage to heart muscle carries a risk of sudden death.
Interventional centre (also known as Heart Attack Centre or PCI 
hospital) - A hospital equipped with catheter laboratories and 
trained staff to perform percutaneous coronary interventions, 
(normally available around the clock).
Myocardial infarction - Often called a heart attack, this means the 
death of the cells of an area of the heart muscle (myocardium) as a 
result of oxygen deprivation, which in turn is caused by blockage of 
the blood supply to the heart.
The National Institute for Health and Care Excellence (NICE) – The 
official body in England which provides national guidance and advice 
to improve health and social care.
Non-ST elevation myocardial) infarction (nSTEMI) - A heart attack 
that occurs without ST segment elevation on the ECG. It usually 
means a coronary artery is partly blocked, so emergency treatment 
to restore the blood flow may not be needed, but the long-term 
prognosis is actually worse than for STEMI.
Percutaneous coronary intervention (PCI) - A technique to re-
open a blocked coronary artery, also called angioplasty. Primary 
PCI means it is carried out as an emergency treatment for a heart 
attack, in which case it must be performed as soon as possible after 
the STEMI is diagnosed to prevent loss of a heart muscle.
Reperfusion - Treatment that improves the blood supply to the 
heart, including PCI or thrombolysis.
Risk adjustment - A process used to account for the impact of 
individual risk factors such as age, severity of illness and other 
medical problems so that different patients and different hospitals 
can more fairly be compared on specific measures.
Statins - Drugs used to reduce cholesterol levels in the blood. 
ST elevation myocardial infarction (STEMI) - A heart attack 
characterized by a specific abnormal appearance on the ECG 
(ST segment elevation) which usually means a coronary artery is 
completely blocked.
ST elevation myocardial infarction (STEMI) - A heart attack 
characterized by a specific abnormal appearance on the ECG 
(ST segment elevation) which usually means a coronary artery is 
completely blocked.
Thrombolysis - Also called fibrinolysis or clot-busting drugs, 
intravenous medications to break down a clot in a coronary artery to 
restore the blood flow to the heart. Formerly the standard treatment 
for STEMI but now PCI is preferred as it is more effective.
Unstable angina - A sudden episode of chest pain, caused by a lack 
of oxygen supply to the heart, which is unpredictable and can occur 
when the patient is at rest. It is a type of acute coronary syndrome 
and should be treated as an emergency.
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Appendix 2: Published research using MINAP data 
MINAP is a rich source of data about heart attack patients in the 
UK and how they are treated. It is regularly used by researchers as 
a basis for peer-reviewed scientific studies. These can tell us more 
about different aspects of coronary heart disease and treatments, 
and help to improve standards as well as increasing scientific 
understanding of this important area. 
This is a list of studies based on MINAP data published during 
2015 and the first half of 2016. A complete list can be found at 
www.ucl.ac.uk/nicor/audits/minap.
Hall M, Dondo TB, Yan AT, Goodman SG, Bueno H, Chew DP, 
Brieger D, Timmis A, Batin PD, Deanfield JE, Hemingway H, 
Fox KA, Gale CP. Association of Clinical Factors and Therapeutic 
Strategies With Improvements in Survival Following Non-ST-
Elevation Myocardial Infarction, 2003-2013. JAMA. 2016 Sep 
13;316(10):1073-82. doi: 10.1001/jama.2016.10766.
Wu J, Gale CP, Hall M, Dondo TB, Metcalfe E, Oliver G, Batin 
PD, Hemingway H, Timmis A, West RM. Impact of initial hospital 
diagnosis on mortality for acute myocardial infarction: A national 
cohort study. Eur Heart J Acute Cardiovasc Care. 2016 Aug 29. pii: 
2048872616661693. 
Alabas OA, Hall M, Dondo TB, Rutherford MJ, Timmis AD, Batin PD, 
Deanfield JE, Hemingway H, Gale CP. Long-term excess mortality 
associated with diabetes following acute myocardial infarction: a 
population-based cohort study. J Epidemiol Community Health. 2016 
Jun 15. pii: jech-2016-207402. doi: 10.1136/jech-2016-207402.
Dondo TB, Hall M, Timmis AD, Gilthorpe MS, Alabas OA, Batin 
PD, Deanfield JE, Hemingway H, Gale CP. Excess mortality and 
guideline-indicated care following non-ST-elevation myocardial 
infarction. Eur Heart J Acute Cardiovasc Care. 2016 May 3. pii: 
2048872616647705.
Walker S, Asaria M, Manca A, Palmer S, Gale CP, Shah AD, Abrams 
KR, Crowther M, Timmis A, Hemingway H, Sculpher M. Long-
term healthcare use and costs in patients with stable coronary 
artery disease: a population-based cohort using linked health 
records (CALIBER). Eur Heart J Qual Care Clin Outcomes. 2016 Jan 
20;2(2):125-140.
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Alabas O A, Norman P, Deanfield J E, Bloor K, Hemingway H, Gale 
C P; Geographic variation in the treatment of non-ST-segment 
myocardial infarction in the English National Health Service: a cohort 
study. BMJ Open 2016;6: e011600 doi:10.1136/bmjopen-2016-011600 
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Cookson R, Norman P, Timmis A, de Belder M, Ludman PF, 
Gale CP; National Institute for Cardiovascular Outcomes Research 
(NICOR). Patient and hospital determinants of primary percutaneous 
coronary intervention in England, 2003-2013. Heart. 2016; 5. pii: 
heartjnl-2015-308616. doi: 10.1136/heartjnl-2015-308616. 
Tonne C, Halonen JI, Beevers SD, Dajnak D, Gulliver J, Kelly FJ, 
Wilkinson P, Anderson HR. Long-term traffic air and noise pollution 
in relation to mortality and hospital readmission among myocardial 
infarction survivors. Int J Hyg Environ Health. 2016;219(1):72-8. 
Rashid S, Simms A, Batin P, Kurian J, Gale CP World J Cardiol. 
Inequalities in care in patients with acute myocardial infarction. 
World J Cardiol. 2015 Dec 26;7(12):895-901. DOI: 10.4330/wjc.
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Myint PK, Zaman MJ. Effect of age on the prognostic value of left 
ventricular function in patients with acute coronary syndrome: A 
prospective registry study. Eur Heart J Acute Cardiovasc Care. 2015, 
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L, Timmis A, Jernberg T, Hemingway H; Comparison of hospital 
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nationwide clinical registries. BMJ. 2015;351:h3913. doi: 10.1136/
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Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-
Rodriguez M, Gale CP, Deanfield J, Smeeth L, Timmis A, 
Hemingway H. Type 2 diabetes and incidence of cardiovascular 
diseases: a cohort study in 1.9 million people. Lancet Diabetes 
Endocrinol. 2015; 3: 105–13. DOI 10.1016/S2213-8587(14)70219-0
Brown RA, Varma C, Connolly DL, Ahmad R, Shantsila E, Lip GY. 
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time but not mortality. Int J Cardiol. 2015;186:226-30 DOI 0.1016/j.
ijcard.2015.03.172
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